Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	138.48B
Revenue (ttm)	17.11B
Net Income (ttm)	834.60M
Shares Out	316.16M
EPS (ttm)	2.78
PE Ratio	157.55
Forward PE	114.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	141,035
Average Volume	301,247
Open	428.50
Previous Close	429.95
Day's Range	428.50 - 440.25
52-Week Range	327.40 - 463.85
Beta	n/a
RSI	68.94
Earnings Date	Aug 8, 2025

About Dr. Agarwal's Health Care

Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 4,214
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In 2024, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.